Company: FENC
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001558370-25-005563
Chunk: 36

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 36
---
 aggregate dollar value that would have been realized if the options under the option-based award had been exercised on the vesting date. The dollar value was computed by determining the difference between the closing market price of the Common Shares on the Nasdaq at the deemed exercise on the vesting date and the exercise price. |

Page22

Compensation of Directors Director Compensation Table The following table summarizes the compensation earned by our non-executive directors for the year ended December 31, 2024.

| ​             | ​ | ​                 |       ​ | ​ | ​            | ​ | ​ | ​                   |       ​ | ​ | ​     |       ​ |
| Name          |   | Fees paid in Cash |         |   | Stock Awards |   |   | Option Awards(1)(3) |         |   | Total |         |
| Mr. Raykov(2) | ​ | ​                 |       — | ​ | ​            | — | ​ | ​                   |       — | ​ | ​     |       — |
| Dr. Islam     |   | ​                 | 100,000 |   | ​            | — |   | ​                   |  82,061 |   | ​     | 182,061 |
| Dr. Brughera  |   | ​                 |  77,500 |   | ​            | — |   | ​                   |  65,649 |   | ​     | 143,149 |
| Dr. Cook      |   | ​                 |  62,500 |   | ​            | — |   | ​                   |  65,649 |   | ​     | 128,149 |
| Mr. Rallis    |   | ​                 |  82,500 |   | ​            | — |   | ​                   |  65,649 |   | ​     | 148,149 |
| Total         | ​ | $                 | 322,500 | ​ | $            | — | ​ | $                   | 279,009 | ​ | $     | 601,509 |

| (1) | Represents the aggregate grant date fair value computed in accordance with FASB ASC Topic 718. |

| (2) | Mr. Raykov become a non-executive director effective upon his resignation as CEO in August 2024. Includes only compensation, if any, received in his capacity as director and excludes compensation received by Mr. Raykov as CEO. |